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The American College of Cardiology is, of course, an 
advocate and supporter ofclinical cardiovascular research. 
Yet, how specifically the College “fosters” research has not 
been clearly articulated. As discussed in a previous Presi- 
dent’s Page, the Strategic Planning Committee is spearhead- 
ing this effort by taking a critical ook at the College’s 
potential for encouraging more practitioner involvement in 
clinical research (1). Toward this end, the Committee initiated 
a study involving 24 in-depth telephone interviews with ACC 
members in private practice. This study was designed to: 
understand members’ interest in and perception of the 
importance and benefit of participating i  clinical trials; 
explore with members who have participated in clinical 
trials their attitudes and barriers they encountered; 
explore with members who have not participated in 
clinical trials or other clinical research t eir easons for 
not participating; 
listen to members’ recommendations for increasing 
clinical research participation; and 
@ listen to members’ thoughts about he future role of the 
College in fostering research. 
The findings of this qualitative study are highlighted 
below, together with some of my own thoughts on where we 
go from here. 
Attitude toward participation in clinical trials. It came as 
no surprise that the physicians interviewed concurred with 
the importance of participating in clinical trials, while also 
believing that here is a diminishing number of physicians in
private practice who do participate. Their perception fwhy 
this dilemma exists includes the following: 
0 Practicing physicians believe that e increased com- 
plexity of research protocols has resulted in an inevita- 
ble shift of private industry research support t  large 
academic centers that have the large patient popufa- 
tions, manpower and facilities to support the trials. 
However, some respondents maintain that there is a 
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long-standing division between the acade 
d the general practice community (i.e., the 
“town-gown” problem). 
Severa! physicians are not participating in research 
because d the “burdensome” administrative re 
ments of current research trials. 
Members pointed to concerus (i.e., admi~strative has- 
sles) associated with malpractice insurance as a partic- 
ularly i-mportant culprit. 
Although lack of sufficient time (mainly due 
administrative help) is the primary reason for 
participation in clinical research trials, some 
also attributed their lack of involvement to increasingly 
“dangerous” research protocols and the culty of 
recruiting private pati s for such trials. 
xperience in clinical t s. Cardiologists who ad re- 
cently participated in clinical trials generally felt that their 
involvement influenced their private practice in positive 
ways. They had heard about new medications and proce- 
dures, and had gained personal isfaction from being on 
the “cutting edge” of medical antes. However, many 
said that the administrative and e demands of the trials 
placed astrain on their staff members and their practice. As 
might be expected, physicians with a large private practice 
or a hospital-based practice were more likely to incorporate 
research into their practice without disruptive effects. 
Regarding the financial reimbursement received for their 
participation, most physicians interviewed were satisfied, 
particularly because the financial reward was not perceived 
as their primary incentive. 
Most physicians questioned about heir expectations for
future involvement intrials indicated a desire to do more 
research, but remarked that it would depend on the time 
demands of the trial and the availabihty of administrative 
staff. Moreover, members set high standards for the clinical 
trials in which they would participate. Several noted they are 
cautious about aking part in t als designed to promote a
particular drug-the so-called 
Nonparticipation in clinical trials. Among members who 
indicated they had not participated in clinical trials, most 
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research activities, such as cost-be 
crease ~art~c~~atio~ 
trialis were desi 
ticipation i clinical trials research would encourage private 
to become involved. Yet, aside from the time and 
centives, one of the significant barriers to partic- 
ipation, according to physicians interviewed, is a perceived 
ate in clinical research. So of their specific rec.- 
ommendat~o~s were that the ACC could 1) he@ to increase 
participation i clinical trials simply by ‘“spreading the 
word” about the importance of research :,.nd ways in which 
arrier to greater iov~$ve- 
our future. 
On this last point, I am 
that our Chapters have 
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